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ABSTRACT
Objectives: To improve understanding of the preclinical stage of colonic inflammation by
exploring the existence of a link between early inflammatory changes in the colonic mucosa
and the systemic redox balance.
Methods: Clinical characteristics, a fasting blood draw, and mucosal biopsies from the right, left,
and sigmoid-rectum colonic tracts collected from 28 healthy individuals (14/14 males/females)
who underwent colonoscopy. Myeloperoxidase (MPO) positive cells infiltrating colonic mucosa
specimens were assessed by immunohistochemistry, and patients divided into high or low MPO
expressing cells/optical field groups (MPOhigh or MPOlow, respectively).The systemic oxidative
balance has been studied through derived-Reactive Oxygen Metabolites (d-ROMs), Biological
Antioxidant Potential (BAP), and Lipoperoxide-cholesterol Oxidizing (LP-CHOLOX) tests on
serum.
Results: MPOhigh patients demonstrated an increased systemic oxidative stress compared to
MPOlow individuals (P = 0.035), especially when MPO is referred to the left-sided colonic
mucosa (P = 0.007). MPOlow subjects in the sigmoid-rectum showed a significant higher
antioxidant capacity in the serum (P < 0.02). Sex-specific differences in MPO expression (male
and female: 4.6 ± 3.2 and 2.6 ± 1.5 MPO-positive cells/optical field, respectively, P = 0.044),
and a decreasing gradient in MPO expression moving from the cecum to the rectum
(ascendant, descendant, and sigmoid-rectum: 3.7 ± 2.8, 3.1 ± 1.7, and 1.4 ± 0.5, respectively, P
= 0.012) were also found and discussed.
Discussion: The study is the first demonstrating a connection between systemic redox balance
and MPO expression in the colonic mucosa, according to the colonic tract and patient gender.
Further research evaluating the MPO expression in the human colon and its relationship with
pathological conditions could benefit from these results.
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Introduction
Subclinical pro-inflammatory status of the colorectal
mucosa is a fundamental early determinant of many
severe conditions, such as inflammatory bowel dis-
eases (IBDs) [1–4] and colorectal carcinogenesis [5–8].
We know that the effects of these pathological con-
ditions spread out of the colonic mucosa, thus affecting
the whole body [9] and producing alterations in sys-
temic inflammatory markers and distant organs
[10,11], also mediated by substantial changes in the
systemic redox balance [8,12–17].
In this process, myeloperoxidase (MPO) is emerging
as a key player. Expressed in the tissues as well as in cir-
culating leukocytes [18–20], MPO is a heme-containing
peroxidase released extracellularly and into phagoso-
mal compartments by neutrophils, monocytes, and
some tissue macrophages, where it catalyzes the reac-
tion of halide and pseudohalide ions with hydrogen
peroxide (H2O2) to generate hypohalous acids [21].
Indeed, its activity is tightly related to local and sys-
temic redox balance, as demonstrated by previous
research [22,23]. Although MPO has been increasingly
recognized for its role in promoting and maintaining
IBDs and colorectal carcinogenesis, conflicting evi-
dence remains. In particular, an apparent dichotomy
concerning the role of MPO expression on carcinoge-
netic processes exists [24]. On the one hand, MPO
seems to promote colorectal carcinogenesis [25–27],
while on the other hand higher MPO expression has
shown to repress cancer progression and thus
improve patient prognosis [28,29]. Other findings that
remain to be clarified concern the different epidemiol-
ogy of colorectal carcinogenesis in relation to gender
(right-sided colorectal cancer is more frequent in
females) as well as to the different colonic tracts [30,31].
Prompted by this background, we hypothesized
that MPO expression is not uniformly represented in
the large bowel, and varying levels of expression may
relate to the systemic oxidative balance, thereby in
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turn affecting the early steps of inflammation-related
carcinogenesis. Thus, in this study, the presence and
entity of systemic oxidative stress have been investi-
gated in relation to the distribution of MPO-positive
cell infiltrates in the normal-appearing colorectal
mucosa.
Material and methods
Ethics statement
All patients enrolled in the present study were asked to
provide written informed consent, and the study proto-
col was specifically approved by the local Ethics Com-
mittee (‘Comitato Etico Provinciale di Modena’ Prot.
No. 4396/C.E.).
Study population and sample processing
Twenty-eight consecutive patients (M/F 14/14) who
underwent colonoscopy for non-specific abdominal
symptoms (recurrent abdominal pain, constipation
without body weight loss) as prescribed by their
primary care physician were enrolled in the study
after joining by written informed consent. Two
samples of normal mucosa for each colonic segment
(right colon and left colon) and one sample for the
sigmoid-rectum were collected from each of the 28
patients during colonoscopy; they were fixed in forma-
lin and embedded in paraffin for immunohistochemis-
try. All patients had a negative colonoscopy. Before the
colonoscopy, a blood draw for serological analysis was
collected and immediately processed. Sera were stored
frozen at −80°C until the execution of oxidative stress
tests. Glycemia has been measured directly from the
patients with a glucometer for clinical use (Breeze 2
Glucometer, Bayer AG, Germany). For each patient,
we collected demographic (age and sex) and anthropo-
metric characteristics (height, waist circumference,
body weight, BMI (body weight in kg/height in m2),
waist-to-hip ratio, and blood pressure). Patients were
negative for significant events in past medical history
and drug assumption. Serological and immunohisto-
chemistry tests were performed in blind for anthropo-
metric data and other clinical records.
Immunohistochemistry and scoring for MPO
expression
MPO expression has been calculated as the mean
number of positive cells per optical field (cells/OF).
Detailed procedures for the immunohistochemistry
technique are reported in our previous study [27].
Before immunohistochemistry, a routine histology of
tissue samples was carried out after hematoxylin and
eosin staining of the sections. To assess the number
of MPO-positive cells expressed in the colorectal
mucosa, a quantitative score was used, counting the
number of stained cells by immunohistochemistry
under a light microscope. Two slides for each sample
(about three samples for each patient) were scored
by the analysis of at least 25 microscopic fields (magni-
fication ×100). Cells located in capillary vessels were
excluded by the observers. Slides were scored by two
independent observers. Then, the mean number of
MPO-positive cells (positive cells/OF) for each patient
was calculated for the entire colon-rectum, and for
each large bowel segment: right colon (cecum to prox-
imal half of the transverse colon), left colon (distal half
of the transverse colon and descending colon), and the
sigmoid-rectum. Increased MPO expression has been
defined for patients that express higher values than
the mean number of positive cells/OF according to a
specific colonic tract (and defined as MPOhigh subjects),
whereas low MPO expression patients corresponded to
lower values than mean positive cells/OF in a particular
colonic tract (and defined as MPOlow subjects).
Oxidative stress assessment
Three tests have been used to assess the redox proper-
ties of the serum samples: d-ROMs test, LP-CHOLOX
test, and BAP test produced by Diacron International®,
Inc. (Grosseto, Italy), and performed using the dedi-
cated platform FREE Carpe Diem©. The platform con-
sists in a photometer with six interference filters to
measure the absorbance of the solution (serum plus
reagents) in accordance with the specific test pro-
cedures. FREE Carpe Diem© platform and tests are
approved for in vitro diagnostic use.
d-ROMs (derived-Reactive Oxygen Metabolites)
assay is used to measure the oxidant ability of a
serum sample towards 4-amino-N,N-diethylaniline
sulfate used as chromogen. Especially alkoxyl e hydro-
peroxyl radicals, derived from hydroperoxides (ROOH),
help to determine the oxidizing capacity measured by
d-ROMs test. Units are expressed as Carratelli units
(CARR U) whose 1 CARR U corresponds to 0.08 mg
hydrogen peroxide/dl. Reference values for d-ROMS
test are as follows: normal, up to 299 CARR U; border-
line values, between 300 and 320 CARR U; low-level oxi-
dative stress between 321 and 340 CARR U; middle
level oxidative stress between 341 and 400 CARR U;
high level oxidative stress between 401 and 500
CARR U; very high level 500 CARR U or more [32–34].
LP-CHOLOX (Lipoperoxide-cholesterol Oxidizing)
test measures photometrically the level of lipoperox-
ides in the serum, resulting mainly from cholesterol,
by means of their ability to facilitate the oxidation of
Fe2+ ion to Fe3+. The produced Fe3+ bounds to thiocya-
nate developing a color complex photometrically mea-
surable. The increase in absorbance is directly
proportional to the concentration of lipoperoxides
present in the serum. Units are expressed in μEq/L.
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Reference values are the following: normal, up to
599 μEq/L; slight alteration, between 600 and
799 μEq/L; moderate alteration, 800–999 μEq/L;
strong alteration, 1000 μEq/L or more [35].
BAP (Biological Antioxidant Potential) test has been
used to assess antioxidant properties of the sera. BAP
allows determining the concentration of antioxidants
through the ability to reduce the iron ion from ferric
(Fe3+) to the ferrous (Fe2+) form in an iron chloride sol-
ution (2%). BAP test provides an overall measure of
many antioxidants such as bilirubin, uric acid, vitamins
C and E, and proteins. Units are expressed in μmol L−1.
Reference values: optimal, 2200 μmol L−1 or more; bor-
derline condition, 2200–2000 μmol L−1; slight
reduction, 1999–1.800 μmol L−1; moderate reduction,
1.799–1.600 μmol L−1; strong reduction, 1.599–
1.400 μmol L−1; very strong reduction, 1.400 μmol L−1
or less [36,37].
Statistical analysis
Statistical analysis was performed using SigmaPlot 12,
Systat Software, Inc., London (UK). Continuous variables
were expressed asmean ± standard deviation (SD). Nor-
mality test (Shapiro–Wilk) and Equal Variance Test were
used to assess data distribution. Kruskal–Wallis ANOVA
on Ranks test has been used to evaluate differences in
data among non-normal distributed values. One-way
ANOVA has been used for normally distributed data.
Pearson Moment Correlation test was used for measur-
ing the strength of association between pairs of vari-
ables expressed by continuous numeric values. The
level of statistical significance was set at P < 0.05.
Results
Demographic and anthropometric characteristics of
the patients are shown in Table 1. Mean BMI was
26.7 ± 4.2 kg m−2, waist circumference and waist-to-
hip ratio resulted slightly increased as well (98.8 ±
14.3 and 0.94 ± 0.08 cm, respectively), indicating that
our sample of patients was on average overweight.
Mean age, BMI, systolic blood pressure, waist circumfer-
ence, and glycemia were not significantly different
between male and female patients, while remarkable
was the difference in the mean values for the waist-
to-hip ratio (male and female, 1.00 ± 0.05 and 0.89 ±
0.08, respectively, P < 0.001), and diastolic blood
pressure (male and female, 81.8 ± 4.9 and 71.6 ±
9.9 mmHg, respectively, P = 0.003). A significant covar-
iation has been found between d-ROMs and LP-
CHOLOX test results, as showed in Figure 1.
MPO expression was 2.7 ± 1.7 cells/OF for the entire
colon-rectum; 3.7 ± 2.8 cells/OF for the right colon; 3.1
± 1.7 cells/OF for the left colon; 1.4 ± 0.5 cells/OF for
the sigmoid-rectum. Significant differences between
male and female patients have been observed only for
MPO expression in the right colon (P = 0.044), while for
the other variables such as d-ROMs and LP-CHOLOX,
differences did not reach statistical significance. MPO
expression decreased moving from proximal colon to
sigmoid-rectum with a statistically significant trend, as
reported in Table 2 and Figure 2. Different levels of
MPO immunostaining are illustrated in Figure 3, and
on Supplementary online materials (Figures A to J).
Oxidative stress in relation to MPO expression
Considering the whole colon, oxidative stress in the
serum resulted higher (d-ROMs: 357.9 ± 41.2 CARR U)
in MPOhigh (>2.7 cells/OF) subjects compared to
MPOlow subjects (d-ROMs: 309.3 ± 61.7 CARR U, P =
0.035). Considering each large bowel segment, differ-
ences in d-ROMs values in relation to MPO expression
were especially significant in the left colon, in which
mean d-ROMs for MPOhigh subjects was 358.2 ± 46.4
U CARR compared to 294.9 ± 46.7 CARR U in the
MPOlow subjects (P = 0.007). In the right colon as well
as in the sigmoid-rectum the trend was similar but
without reaching statistical significance (Figure 4).
Figure 1. Simple scatter plot with regression line indicating a
direct correlation between d-ROMs and LP-CHOLOX test results
(ρ 0.45; P = 0.017).
Figure 2. MPO expression varied along the colorectum,
decreasing from the ascending colon to the sigmoid-rectum.
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Adjusting for sex, MPOhigh males showed significant
higher values of systemic oxidative stress compared to
MPOlow males (d-ROMs: MPOhigh and MPOlow, 356.0 ±
42.7 and 284.7 ± 40,1 CARR U, respectively, P = 0.012),
whereas considering the right colon (d-ROMs: MPOhigh
and MPOlow, 340.6 ± 50.5 and 288.5 ± 48.3, respectively,
P = 0.115), the left colon (d-ROMs: MPOhigh and MPOlow,
340.2 ± 51.1 and 286.1 ± 44.6, respectively, P = 0.079),
and the sigmoid-rectum (d-ROMs: MPOhigh and
MPOlow, 322.0 ± 21.6 and 287.2, respectively, P = 0.330)
separately, a statistical significance is not achieved. For
females, a trend with higher d-ROMs values for
increased MPO expression has been found but
without reaching statistical significance.
LP-CHOLOX test resulted slightly increased in
MPOhigh patients but this was not statistically signifi-
cant considering the overall colon (MPOhigh and
MPOlow, 1086.0 ± 571.0 and 965.3 ± 432.9 μEq/L,
respectively; P = 0.53) as well as for each large bowel
segment (right colon: MPOhigh and MPOlow, 1115.8 ±
622.6 and 990.4 ± 430.6 μEq/L, respectively, P = 0.60;
left colon: MPOhigh and MPOlow, 1082.9 ± 561.9 and
856.2 ± 351.1 μEq/L, respectively, P = 0.27; sigmoid-
rectum: MPOhigh and MPOlow, 1105.1 ± 519.4 and
981.8 ± 493.3 μEq/L, respectively, P = 0.57). Also adjust-
ing for sex, there were not significant differences.
Biological antioxidant power (BAP) test resulted
decreased in MPOhigh patients, though a statistical sig-
nificance was observed only in the sigmoid-rectum
segment (MPOhigh and MPOlow, 1428.9 ± 493.2 and
1799.8 ± 162.6 umol L−1, respectively, P < 0.02, Figure
5). Adjusting for sex, male and female groups separ-
ately did not show significant differences.
MPO expression in relation to the other
variables
A significant difference in MPO expression according to
sexwas found in the right colon, wheremales expressed
higherMPOvalues than females (see Table 2).Moreover,
men showed a significant difference in glycemic values
between high expressing vs. low expressing MPO in the
right colon (MPOhigh and MPOlow, 116.8 ± 11.8 and 99.7
± 11.7 mg/dl, respectively, P = 0.04). Females showed
increased mean diastolic blood pressure in the high
expressing MPO group for sigmoid-rectum only
(MPOhigh and MPOlow, 79.0 ± 6.1 and 66 .7 ±
5.2 mmHg, respectively; P = 0.015).
Oxidative stress and clinical metabolic profiles
d-ROMs values in the sera showed no correlation with
anthropometric and metabolic profiles in our subjects,
whereas patients with normal to slightly increased ( <
800 μEq/L) LP-CHOLOX test significantly differ from
patients with higher (≥800 μEq/L) LP-CHOLOX test
values for mean diastolic blood pressure (72.2 ± 9.5
and 81.1 ± 6.8 mmHg, respectively; P < 0.02, Figure 6).
No other significant difference between groups was
found in our patients for LP-CHOLOX test and meta-
bolic/anthropometric parameters.
Significant correlations were found between BAP
test results and several metabolic variables. BAP inver-
sely covariated with glycemic values with a statistically
significant trend, as illustrated in Figure 7, which shows
that increases in glycemic values were associated with
lower antioxidant power (ρ −0.45; P = 0.015). Moreover,
BAP showed significant relationships with BMI (BAP
decreased when BMI increased, ρ −0.41; P = 0.029,
see Figure 8), and waist circumference (higher scores
in BAP were associated with lower mean values for
waist circumference 103.3 ± 14.1 and 89.3 ± 9.5 cm,
patients with BAP ≤ 1800 and BAP > 1800, respectively,
P = 0.012).
Discussion
This is the first study demonstrating a connection
between MPO expression in the colorectal mucosa
and systemic oxidative balance in the blood of
Table 1. Demographic and anthropometric features of the enrolled subjects.
Variables Age BMI Waist† Hip† W/H ratio SBP‡ DBP‡ Glycemia£
All, n = 28 61.9 (11.9) 26.7 (4.2) 98.8 (14.3) 104.3 (9.4) 0.94 (0.08) 142.9 (22.8) 76.5 (9.3) 108.0 (20.2)
Male, n = 14 62.3 (11.5) 27.3 (3.0) 103.3 (11.4) 103.4 (7.3) 1.00 (0.05) 147.7 (18.8) 81.8 (4.9) 108.1 (14.7)
Female, n = 14 61.4 (12.6) 26.1 (5.2) 94.3 (15.8) 105.1 (11.3) 0.89 (0.08) 138.5 (25.9) 71.6 (9.9) 107.9 (25.2)
P value M/F 0.84 0.46 0.09 0.64 < 0.001 0.06 0.003 0.98
Mean (standard deviation). †in centimeters; ‡in mmHg; £in mg/dl; BMI: body mass index; DBP: diastolic blood pressure; SBP: systolic blood pressure; W/H ratio:
waist-to-hip ratio.
Table 2. Serological oxidative balance and colonic mucosa MPO expression.
Variables d-ROMs LP-CHOLOX BAP
MPO-overall
colon
MPO-right
colon
MPO-left
colon
MPO-sigmoid-
rectum
P value MPO
expression
All 326.6 (59.4) 1008.4 (479.8) 1649.0 (347.4) 2.7 (1.7) 3.7 (2.8) 3.1 (1.7) 1.4 (0.5) 0.012
Males 305.1 (51.5) 837.1 (476.5) 1710.5 (228.9) 2.8 (2.0) 4.6 (3.2) 3.0 (2.0) 1.6 (1.2) 0.024
Females 348.2 (60.6) 1179.6 (433.4) 1587.4 (436.0) 2.6 (1.3) 2.6 (1.5) 3.2 (1.3) 1.3 (0.4) 0.011**
P value M/
F
0.053 0.057 0.35 0.75 0.044* 0.75 0.38
Mean (standard deviation). *significant difference between males and females; **left colon vs. sigmoid-rectum.
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healthy subjects. Moreover, our data show that sys-
temic redox balance is related in a different manner
to different colonic segments and gender.
Subjects with a higher number of MPO-positive cells
in the colonic mucosa presented higher values at the d-
ROMs test in the serum, indicating that a stronger oxi-
dative capacity (equivalent to an excess of about
3.9 mg of hydrogen peroxide/dl) characterizes
MPOhigh subjects. The finding was especially significant
considering MPO expression in the left colon. In fact,
MPOhigh individuals for this segment expressed a
marked difference in d-ROMs values compared to
MPOlow patients (358.2 ± 46.4 vs. 294.9 ± 46.7 CARR U,
respectively, P = 0.007). An explanation of this finding
could reside in the emerging fact that the left colon
seems to be less subject to immunosurveillance and
subclinical inflammation than the right one. We can
hypothesize that when an inflammatory response is
triggered in the left colon, the impact on systemic oxi-
dative balance is stronger than it would be in the right
colon. This interpretation is in accordance with other
findings. Indeed, Paski et al. demonstrated that physio-
logically there is an increased inflammatory activity
(such as epithelial injury, crypt architecture distortion,
lamina propria cellularity, and cryptitis) in the cecum
compared to the rectum [38]. Also, intraepithelial T-
cells were shown to be higher in the proximal colon
compared to the distal in healthy adults [39]. Thus,
immune surveillance seems greater in the right colon
than in left colon, and we would expect that a hyper-
expression of MPO in the left colon may reflect a
more severe alteration of the colonic mucosa com-
pared to an excess of MPO expression in the right
colon. Accordingly, higher serum antioxidant capacity
resulted significantly associated with MPOlow
Figure 3. Immunohistochemical staining of MPO-positive cells in healthy human colonic mucosa samples. In (A) the colonic mucosa
does not show a significant presence of MPO-positive cells, whereas in (B) a low/moderate expression is evident as dark-brown
staining between crypts, particularly at the luminal pole. In (C), MPO-positive cells are well-recognizable as dark-brown staining
also more deeply in the stroma at the base of the crypts, where epithelial stem-cell niches are present. Additional Figures (A to
J) are available online.
Figure 4. Bars represent mean ± SD. Mean MPO values on the
X-axis were different according to the different MPO expression
along the large bowel. Differences were statistically significant
between higher/lower than mean MPO expression for the
overall colon (*P = 0.035) and for the left colon (**P = 0.007),
while in the right colon and sigmoid-rectum differences did
not reach the statistical significance (P = 0.18; P = 0.17).
Figure 5. Biological antioxidant power (BAP) test tended to be
higher in patients with lower MPO-positive cells in the colonic
mucosa. A statistically significant difference is appreciable in
the sigmoid-rectum (*P = 0.45; **P = 0.42; P = 0.62; P < 0.02).
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expression in the sigmoid-rectum. In other words, the
more MPO is expressed in the sigmoid-rectum, the
less antioxidant capacity is present in the bloodstream.
These findings point up that proximal and distal
colon are physiologically different, furnishing novel
insight to the existing piece of evidence [30,40–42].
In fact, our data also demonstrate a decreasing trend
in the expression of MPO in the colonic mucosa
moving from the proximal colon to the rectum
(Figure 2). As mentioned before, this probably reflects
a physiological reduced immune surveillance in the
distal colon-rectum. Studies have shown that the
human colon contains complex and diverse microbial
colonies of approximately 1013 to 1014 bacteria [43],
and these numbers increase with a positive gradient
from the proximal colon to distal colorectum [44]. Lee
et al. [45] suggested that mucosal immune cells in
the colorectum have to maintain a delicate balance
between immunogenicity against pathogens and toler-
ance for the commensal microbiota, and the distal col-
orectum would require immune cells to promote
tolerance rather than immunogenicity. Therefore,
since MPO expression is a marker of aspecific
immune activity able to recruit other immune cells
[19] our study supports this hypothesis.
Interestingly, our data show also differences accord-
ing to gender in relation to MPO expression and sys-
temic oxidative balance. We observed a stronger
correlation between higher d-ROMs values and MPO
expression in men than in women. Again, we demon-
strate that MPO expression in the right colon is signifi-
cantly lower in females than in males. The reason could
consist in the different hormonal status. It is well estab-
lished that gender is related to oxidative balance in
both humans and animals [46–48], and estrogens
could actively modulate sex differences in MPO
expression with the evidence of a higher MPO activity
in estrogen deficient animal models [49].
Basing on these considerations, we can attempt to
explain some of the epidemiologic characteristics con-
cerning inflammatory-related colorectal carcinogen-
esis. First of all, right-sided CRCs are more frequent in
females than in males, and we can hypothesize that
the MPOlow status of female’s right colon predisposes
this sex to develop CRC in that colonic segment com-
pared to men. Further studies are however necessary
to elucidate whether other immunological differences
exist between male and female right colon. Moreover,
left colon is considered more prone to develop CRC
[50], even though left-sided CRCs present a better
prognosis than right-sided ones [51]. Along with
other evidence of reduced immunosurveillance, lower
MPO expression in the descendant could explain the
higher incidence of CRC in this site. Finally, a higher
MPO expression in CRC tissues may relate to a better
prognosis indicating a stronger immune response
against the tumor in cancer patients [28,29], while we
can suggest that conflicting evidence in the literature
should be reconsidered keeping in mind the varying
expression of MPO according to the cancer site.
We are aware that the study has some significant
limitations. First, this is a descriptive study, so it
Figure 6. Mean diastolic blood pressures were higher in sub-
jects with high LP-CHOLOX results (≥ 800 μEq/L), P = 0.019.
Figure 7. Simple scatter plot with regression line indicates that
a higher glycemia was associated with a lower antioxidant
power (ρ −0.45; P = 0.015).
Figure 8. BAP results inversely correlated with BMI, indicating
a lower antioxidative potential in the sera of subjects with
higher BMI (ρ −0.41; P = 0.029).
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cannot define causal-effect relationships relying solely
on our data. Moreover, we cannot exclude that the
relationships between MPO-positive cells expression
inside the colonic mucosa and the systemic redox
balance discussed in this study are due to some conco-
mitant factors that we were not able to discriminate
(e.g. differences in the diet or lifestyle).
In conclusion, this study represents the first evi-
dence that the expression of MPO in the large bowel
is related to systemic oxidative balance in healthy indi-
viduals. A higher MPO expression in the colonic
mucosa was associated with a higher oxidative power
in the sera, whereas higher antioxidant potential
(BAP) levels in the sera paralleled a lower MPO
expression in the sigmoid-rectum. Noteworthy, an
interesting decreasing gradient in MPO expression
moving from proximal to distal colon was evident.
These findings strongly support the hypothesis that
systemic oxidative balance in the peripheral blood
could reflect colorectal mucosa pro-inflammatory
alterations, opening a new perspective on the factors
possibly involved in the colorectal carcinogenesis.
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